Part of Medtronic Plc, Warsaw Orthopedic, Inc. is a company headquartered in the United States that operates orthopedic center.

Established in 1945, Amorepacific is Korea’s No.1 beauty company and a blue-chip corporation. Amorepacific owns nearly 30 well-known brands and has been developing rapidly worldwide. Amorepacific pays great attention to product research and development through research centers located in Korea, France, Japan and Shanghai, to develop premium and high quality skincare and cosmetics products. The Group chose Hong Kong as a strategic bridgehead for the expansion of its presence across the Greater China region and the rest of the world. Two flagship brands - LANEIGE and Sulwhasoo, were introduced in Hong Kong in 2002 and 2004 respectively. The eponymous luxury brand – AMOREPACIFIC, was introduced in Hong Kong in 2014. In 2015, ETUDE HOUSE, a playful cosmetics brand, made its debut in the territory. In 2018, the Company set foot in the personal care product market, introducing the Group’s legendary hair care brand ‘Ryo’ into Hong Kong.

Brainsway's patented breakthrough technology launches a new era in brain disorder treatment. A non-invasive, yet highly effective solution, Brainsway can make a difference in the wellbeing and health of millions of patients worldwide. Brainsway's technology releases millions of patients from a bleak cycle of insufficiently effective treatments and unpleasant side effects. Brainsway's treatment was approved by the FDA for Major Depressive Disorder patients*. The technology is also safe, with no systemic effects or long-term side effects, and highly convenient, requiring only brief daily sessions over a couple of weeks. Brainsway's technology has already been applied in thousands of cases worldwide in the framework of clinical studies. It has also been enthusiastically embraced by leading research institutions worldwide, with over 60 clinical trials performed. Brainsway technology is based on a patent registered by the U.S. National Institutes of Health (NIH). Brainsway is dedicated to research and continuously explores treatments for a variety of brain disorders.

Synthesis BV engages in the design and production of synthetic water level regulation products. It offers penstocks, pipeline valves, accessories, channel slide gates, fish migration, float units, overflow pits, pivoted weirs, pipes, dirt grates, butterfly valve, and check valves. The company is headquartered in Emmeloord, the Netherlands.

NUROCHEK is an Australian innovation and a world-first brain activity assessment device. www.nurochek.com is a portable headset using clinically validated, patented technology to actually measure the brain’s electrical activity and send results to a smartphone for analysis and the cloud for storage and future comparison. In 2 minutes NUROCHEK tells us when a player has abnormal brain activity, and when has returned to normal and their doctor can assess they are safe to return to playing. The current standards, such as the SCAT Test is a mixture of assessments, and takes an experienced doctor over 20 minutes. Our revolutionary technology is designed to take the uncertainty, and controversy, out of concussion diagnosis. Whilst critical for elite sports, it’s also for school and community sports. Research shows that the brain’s electrical activity (or EEG) actually changes in concussion, and returns to the pre-concussion baseline alongside clinical recovery. Globally there are 10 million concussions every year, 5 million of these in children and adolescents. The headset will retail for under $500 and the software sell for <$30/user/year. At the elite level of major sports, NUROCHEK will become a vital part of the Head Injury Assessment, in helping team medial staff decide if a player needs to leave the field or can return to the same game. During recovery, and prior to playing again, NUROCHEK will help medical staff analyse that the player is back to pre-injury (“baseline”) brain activity, and can therefore return to sport. Players can be tested after injury and in return to play scenarios, or weekly as a “fit for play” test: not all concussions are witnessed and recognized, and whether they occur at training, in a game, off-field at home or in the school playground, or if multiple smaller (sub-concussive) impacts cause a change in brain function, NUROCHEK will show the change

DePuy Spine, Inc. manufactures orthopedic devices and solutions. It orthopedic and neurosurgical products that address areas of spinal care, includes cervical, aging spine, vertebral body replacement, invasive surgery and area of biologics. The company was founded in 1895 and is headquartered in Raynham, MA.

Part of Medtronic Plc, SDGI Holdings, Inc. is an American company that manufactures medical equipment.

Medacta International SA manufactures and sells orthopedic products. It offers hip products, including stems, cups, heads, and bone cement; knee products, including patient matched cutting blocks, knees, other implants, and navigation systems; spine products, including unconstrained screw technology and cervical intervertebral body fusion devices; and instruments, including cleaning products, decontamination and sterilization products, woodpecker motors and accessories, chana reamer handles, and instruments trays. The company was founded by Alberto Siccardi in 1999 and is headquartered in Castel San Pietro, Switzerland.

Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with musculoskeletal disorders. It classifies products into Innovative Fusion and Disruptive Technology. It operates through the United States and International geographical segments. The company was founded by David C. Paul, David D. Davidar and Andrew Iott in March 2003 and is headquartered in Audubon, PA.

NeuroPace designs develops, manufactures, and markets implantable devices for the treatment of neurological disorders. It offers a responsive Neurostimulator system (RNS) for the treatment of medically refractory partial epilepsy. The company's RNS system consists of implantable components, including RNS neurostimulator that delivers a short train of electrical pulses to the brain, and depth leads and cortical strip leads; and external products, such as the programmer, a laptop computer with proprietary software that has a wand and telemetry interface enabling communication with an implanted RNS neurostimulator. NeuroPace was incorporated in 1997 and is based in Mountain View, California.

Blackstone Medical, Inc. develops cervical, thoracolumbar and biologic products. The company was founded by William G. Lyons III in 1996 and is headquartered in Lewisville, TX.

Synthes USA LP used to manufacture medical devices. The company was founded by Hansjörg Wyss in 1974 and is headquartered in West Chester, PA.

HHS is an information technology company that specializes in providing biosignal processing, a personal exercise management system, and an AI-based risk management system. Its technology features AI-based brainwaves analysis.

Precision Neuroscience Corp. is a company headquartered in New York, NY, that develops brain-computer interface technology platform. The firm was founded by Rapoport Benjamin, Michael Mager, Papageorgiou Demetrios and Mark Hettick. Michael Mager is currently the CEO of the company.\nThe company says this about itself: Precision Neuroscience is working to provide breakthrough treatments for the millions of people worldwide suffering from neurological illnesses. The company is building the only brain?computer interface designed to be minimally invasive, safely removable, and capable of processing large amounts of data.

Zimmer Biomet Spine, Inc., part of Zimvie, Inc., is a company headquartered in Broomfield, CO. The firm manufactures and markets surgical and non-surgical products.

Nihon Medi-Physics Co., Ltd. is a Japanese joint venture company located in Koto-ku focused on pharmaceutical preparations. The firm was founded in 1973. Nobuhiko Tamura is the current CEO of the company.\nThe company says this about itself: Nihon Medi-Physics is engaging in ensuring stable supply and research and development of the products as a leading manufacturer of radiopharmaceuticals in Japan. Based on the technological proficiency and trust built over the years, the company is also working on research and development of \"Theranostics (a combination of therapy and diagnosis),\" which is a novel medical technology to provide optimal medical service to each patient, as well as on the dissemination of nuclear medicine in Asian countries by licensing its products. The company will continue contributing to society by creating values as a life science company.

Zimmer Spine, Inc., a subsidiary of Zimmer Biomet Holdings, Inc., is an American company located in Minneapolis, MN. The firm designs, manufactures and distributes medical devices and surgical tools.

Ingenium Pharmaceuticals GmbH operates as a biopharmaceutical company specializing in the development of small molecule drugs. They develop inhibitors and ligands targeting key enzymes such as proteases and kinases. Their therapeutic compounds are used for the treatment of memory-related and chronic inflammatory disorders. Their focus areas cover human therapeutics, vivo pharmacology, and disease pathology. The company was founded in 1998 and is headquartered in Munich, Germany.